We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABTS icon
12201
Abits Group
ABTS
$4.24M
$25K ﹤0.01%
+1,675
New +$33K
BWEN icon
12202
Broadwind
BWEN
$127M
$25K ﹤0.01%
+15,684
New +$28.1K
CBAT icon
12203
PUT
CBAK Energy Technology Ltd
CBAT
$64.1M
$25K ﹤0.01%
23,000
-16,200
-41% -$18.8K
CETX icon
12204
Cemtrex
CETX
$5.2M
0
CRVS icon
12205
CALL
Corvus Pharmaceuticals
CRVS
$1.25B
$25K ﹤0.01%
25,400
-28,700
-53% -$35.2K
HOOK
12206
PUT
DELISTED
HOOKIPA Pharma
HOOK
$25K ﹤0.01%
1,510
-4,330
-74% -$71.7K
LDI icon
12207
CALL
loanDepot
LDI
$303M
$25K ﹤0.01%
+17,700
New +$47.8K
AIXC
12208
CALL
AIxCrypto Holdings Inc
AIXC
$13.7M
$25K ﹤0.01%
86
-13
-13% -$3.79K
OLOX
12209
Olenox Industries
OLOX
$3.7M
$25K ﹤0.01%
+2
New +$23.3K
SPIR icon
12210
PUT
Spire Global
SPIR
$567M
$25K ﹤0.01%
2,663
-2,800
-51% -$35.9K
UAVS icon
12211
PUT
AgEagle Aerial Systems
UAVS
$63.9M
$25K ﹤0.01%
38
-6
-14% -$4.99K
WPRT
12212
CALL
Westport Fuel Systems
WPRT
$33.4M
$25K ﹤0.01%
2,490
+600
+32% +$7.43K
IMG
12213
CALL
DELISTED
CIMG Inc
IMG
$25K ﹤0.01%
+35
New +$36.3K
ASXC
12214
PUT
DELISTED
Asensus Surgical, Inc.
ASXC
$25K ﹤0.01%
61,800
+4,700
+8% +$2.1K
NIRWW
12215
DELISTED
Near Intelligence, Inc. Warrant
NIRWW
$25K ﹤0.01%
321,099
-15,455
-5% -$2.19K
OTMO
12216
DELISTED
Otonomo Technologies Ltd. Ordinary shares
OTMO
$25K ﹤0.01%
1,568
+773
+97% +$16.5K
ILLM
12217
CALL
DELISTED
illumin Holdings Inc. Common Shares
ILLM
$25K ﹤0.01%
+10,900
New +$29.3K
MTL.PR
12218
DELISTED
Mechel PAO American Depositary Shares (each representing one-half of a Preferred Share)
MTL.PR
$25K ﹤0.01%
58,229
BKKT icon
12219
Bakkt Inc
BKKT
$345M
$24K ﹤0.01%
456
-5,775
-93% -$486K
HITI
12220
High Tide
HITI
$206M
$24K ﹤0.01%
+12,173
New +$36.1K
JAGX icon
12221
CALL
Jaguar Health
JAGX
$4.5M
0
RJET
12222
CALL
Republic Airways Holdings
RJET
$952M
$24K ﹤0.01%
+720
New +$33.8K
NCNA
12223
NuCana
NCNA
$6.62M
$24K ﹤0.01%
+7
New +$25.9K
SIFY
12224
CALL
Sify Technologies
SIFY
$1.13B
$24K ﹤0.01%
+2,083
New +$29.4K
SLS icon
12225
PUT
SELLAS Life Sciences
SLS
$2.58B
$24K ﹤0.01%
10,800
-10,600
-50% -$31.1K

Similar funds

Citadel Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.